Macrophages: The Road Less Traveled, Changing Anticancer Therapy.

Macrophages: The Road Less Traveled, Changing Anticancer Therapy.
复制标题

DOI:
10.1016/j.molmed.2018.03.006
复制
发表时间:
2018-05
影响因子:
13.6
通讯作者:
Guerriero JL
Guerriero JL
中科院分区:
医学1区
文献类型:
--
作者:
Guerriero JL

文献摘要

参考文献

被引文献

相似文献

巨噬细胞存在于所有脊椎动物的组织中,并且已经作为在发育、组织稳态和疾病中具有复杂作用的多种细胞出现。巨噬细胞是肿瘤微环境的主要组成部分,它们根据其状态促进或抑制肿瘤发生和转移。靶向巨噬细胞进行抗癌治疗的成功临床前策略目前正在临床上进行评估,并提供了该策略可能增强当前疗法的概念验证;然而,临床成功有限。这篇综述讨论了靶向巨噬细胞用于抗癌治疗的前景,但强调了关于它们的个体发生,调节和组织特异性多样性有多少是未知的。进一步的工作可能会识别不同组织中的巨噬细胞亚群,这可能会揭示抗癌治疗的新治疗机会。
Macrophages are present in all vertebrate tissues and have emerged as multifarious cells with complex roles in development, tissue homeostasis and disease. Macrophages are a major constituent of the tumor microenvironment, where they either promote or inhibit tumorigenesis and metastasis, depending on their state. Successful preclinical strategies to target macrophages for anti-cancer therapy are now being evaluated in the clinic and provide proof-of-concept that this strategy may enhance current therapies; however, clinical success has been limited. This review discusses the promise of targeting macrophages for anti-cancer therapy, yet highlights how much is unknown regarding their ontogeny, regulation and tissue specific diversity. Further work might identify subsets of macrophages within different tissues, which could reveal novel therapeutic opportunities for anti-cancer therapy.
DOI: 10.1016/j.drup.2012.01.006
发表时间: 2012-02
影响因子: 24.3
作者:
Correia, Ana Luisa;Bissell, Mina J.
通讯作者: Bissell, Mina J.
DOI: 10.1182/blood-2005-01-0428
发表时间: 2006-03-01
期刊: BLOOD
影响因子: 20.3
作者:
Biswas, SK;Gangi, L;Sica, A
通讯作者: Sica, A
DOI: 10.1186/s40425-017-0257-y
发表时间: 2017-07-18
影响因子: 10.9
作者:
Cannarile MA;Weisser M;Jacob W;Jegg AM;Ries CH;Rüttinger D
通讯作者: Rüttinger D
DOI: 10.1038/nri3071
发表时间: 2011-10-10
期刊: Nature reviews. Immunology
影响因子: --
作者:
通讯作者: --
DOI: 10.1038/ni.2967
发表时间: 2014-10
期刊: Nature immunology
影响因子: 30.5
作者:
通讯作者: --